https://www.healthcaretribunefrance.com/article/910237340-solaris-endovascular-receives-fda-breakthrough-device-designation-for-solaris-de-a-new-drug-eluting-covered-stent Healthcare Tribune France en PressRelease 2026-05-05T11:00:35+00:00 Solaris Endovascular Receives FDA Breakthrough Device Designation for Solaris DE™, a new Drug-Eluting Covered Stent https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24460542-de-stent-with-drug-on-edges-620x397.jpeg https://www.healthcaretribunefrance.com/article/910439198-abivax-announces-repurchase-of-royalty-certificates-and-pricing-of-45m-38-5m-offering-of-american-depositary-shares Healthcare Tribune France en PressRelease 2026-05-05T06:00:00+00:00 Abivax Announces Repurchase of Royalty Certificates and Pricing of $45M (€38.5M) Offering of American Depositary Shares https://ml-eu.globenewswire.com/media/5470cd7e-c1fe-402f-8673-925c82bbd2fb/small/abivax-logo-rgb-png.png